Felipe de Jesús Rodríguez-Gaxiola

Felipe de Jesús Rodríguez-Gaxiola

Auto-generated profile, based on publicly available information

Felipe de Jesús Rodríguez-Gaxiola

Affiliation Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Estado de México, México

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
CVCarlos Arturo Vázquez-Chacón
Carlos Arturo Vázquez-Chacón
FRFelipe de Jesús Rodríguez-Gaxiola
Felipe de Jesús Rodríguez-Gaxiola
CLCruz Fernando López-Carrera
Cruz Fernando López-Carrera
MCMayra Cruz-Rivera
Mayra Cruz-Rivera
AMArmando Martínez-Guarneros
Armando Martínez-Guarneros
PLPaúl Alexis López-Durán
Paúl Alexis López-Durán
Identifying the Mycobacterium tuberculosis resistance mutation patterns is of the utmost importance to assure proper patient’s management and devising of control programs aimed to limit spread of disease. Zoonotic Mycobacterium bovis infection still represents a threat to human health, particularly in dairy production regions. Routinary, molecular characterization of M. bovis is performed primarily by spoligotyping and mycobacterial interspersed repetitive units (MIRU) while next generation sequencing (NGS) approaches are often performed by reference laboratories. However, spoligotyping and MIRU methodologies lack the resolution required for the fine characterization of tuberculosis isolates, particularly in outbreak settings. In conjunction with sophisticated bioinformatic algorithms, whole genome sequencing (WGS) analysis is becoming the method of choice for advanced genetic characterization of tuberculosis isolates. WGS provides valuable information on drug resistance and compensatory mutations that other technologies cannot assess. Here, we performed an analysis of the most frequently identified mutations associated with tuberculosis drug resistance and their genetic relationship among 2,074 Mycobacterium bovis WGS recovered primarily from non-human hosts. Full-length gene sequences harboring drug resistant associated mutations and their phylogenetic relationships were analyzed. The results showed that M. bovis isolates harbor mutations conferring resistance to both first- and second-line antibiotics. Mutations conferring resistance for isoniazid, fluoroquinolones, streptomycin, and aminoglycosides were identified among animal strains. Our findings highlight the importance of molecular surveillance to monitor the emergence of mutations associated with multi and extensive drug resistance in livestock and other non-human mammals.